Tan X, Xiao GY, Wang S, Shi L, et al. EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer. J Clin Invest 2023 Feb 9:e165863. doi: 10.1172/JCI165863.
PMID: 36757799